Evidence map›Paper›PMID 41296162›Full record

ArticleDiscover oncology2025

Exploring the causal relationship between gut microbiota, circulating inflammatory proteins, and colorectal neuroendocrine tumors: a Mendelian randomization study.

Jie Cui, Tie-Jun Wang, Yue-Chen Zhao, Xuan-Peng Zhou

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jie CuiDepartment of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, 200092, Shanghai, China.
Tie-Jun WangDepartment of Radiation Oncology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Yue-Chen ZhaoDepartment of Radiation Oncology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Xuan-Peng ZhouDepartment of Gastrointestinal and Colorectal Surgery, Union Hospital of Jilin University, Changchun, Jilin, China. xpzhou22@mails.jlu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota may influence the occurrence and development of colorectal neuroendocrine tumors (CR-NETs), with inflammatory mediators potentially playing an important intermediary role. However, the current research evidence is insufficient to support this view. In this study, we extracted SNP data from different Genome-Wide Association Study (GWAS) summary statistics. Using bidirectional two-sample Mendelian randomization (MR), two-step MR, and multivariable Mendelian randomization (MVMR) methods, we explored the causal relationship between gut microbiota, inflammatory proteins, and CR-NETs. Our study found that five types of gut microbiota (family Acidaminococcaceae, family Porphyromonadaceae, genus Oscillospira, genus Paraprevotella, genus Ruminococcaceae NK4A214 group) and five inflammatory mediators (C-C motif chemokine Ligand 4, C-C motif chemokine Ligand 23, TNF-related apoptosis-inducing ligand, C-X-C motif chemokine Ligand 5, Monocyte chemoattractant protein 2) have a causal relationship with CR-NETs. Additionally, C-C motif chemokine Ligand 23 (CCL23) mediated the causal effect of family Porphyromonadaceae on CR-NETs (with a mediation proportion of 6.3%), while C-C motif chemokine Ligand 4 (CCL4) mediated the causal effect of genus Ruminococcaceae NK4A214 group on CR-NETs (with a mediation proportion of 4.7%). There is a causal relationship between gut microbiota and inflammatory proteins in the development of CR-NETs, with CCL23 and CCL4 possibly playing a mediating role.

Identifiers

PMID41296162
PMCPMC12748381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.